Representative collaborations include:
Commercialization and Development
- Prestara™ for systemic lupus erythematosus
- Commercialization and marketing license for North America - Watson Pharmaceuticals, Inc.
- Development and commercialization license for Asia (excluding Japan), Australia and New Zealand - Genovate Biotechnology Co. Ltd.
- Commercialization and marketing license for Israel, Gaza and the West Bank - Teva Pharmaceuticals Industries Ltd.
- Hepatitis E Virus Vaccine
- Worldwide exclusive development and commercialization license - GlaxoSmithKline
- Hepatitis C Virus
- Drug discovery, development, and worldwide commercialization
for novel non-nucleoside inhibitors of NS5b polymerase –
- DNA Amplification Technology
- Non-exclusive license - Affymetrix
- Hepatitis G Virus / Human Immunodeficiency Virus
- Non-exclusive license and research collaboration - University of Iowa Research Foundation
- Hepatitis C Virus Diagnostics
- Exclusive worldwide - Chiron Corporation & Bio-Rad
- Hepatitis E Virus Diagnostics
- Non-exclusive worldwide - Abbott Laboratories, Inc. &
Genelabs Diagnostics (a subsidiary of MP Biomedicals)
- Hepatitis G Virus Diagnostics
- Co-exclusive worldwide - Chiron Corporation, Ortho Diagnostics Systems and Roche Diagnostics
© Genelabs Technologies, Inc. All rights reserved. -